Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03620708 · ClinicalTrials.gov registry record · Phase 4
Tobacco and Socioeconomic Disadvantage
A Phase 4 study of Tobacco Smoking, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 4
- Development phase
- 58
- Enrollment target
- 1
- Study location
NCT03620708: Completed Phase 4 study of Tobacco Smoking, sponsored by Rutgers, The State University of New Jersey.
NCT03620708 is a Phase 4 study of Tobacco Smoking that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 58 participants, below the 476-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03620708, a Phase 4 study of Tobacco Smoking, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized clinical trial comparing 3 brief interventions designed to increase motivation to quit smoking in socioeconomically disadvantaged smokers.
Primary Outcome
A self-described "serious" attempt to quit smoking cigarettes since the initial study appointment, measured by the "Quitting Preparation and Actions Questionnaire."
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing
- DRUG Nicotine Replacement Therapy Sampling
- BEHAVIORAL Referral Only
Study Locations (1)
New Jersey
- Division of Addiction Psychiatry - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2018-05-30 |
| Est. Completion | 2018-10-01 |
| Phase | Phase 4 |
What the finished NCT03620708 record still lists
NCT03620708 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 476-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Tobacco Smoking appearing as the primary indexed condition, and to 3 interventions - of which Motivational Interviewing is the first listed.
NCT03620708 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT03620708 about?
NCT03620708 is a clinical study titled "Tobacco and Socioeconomic Disadvantage". Randomized clinical trial comparing 3 brief interventions designed to increase motivation to quit smoking in socioeconomically disadvantaged smokers.
What is the current status of trial NCT03620708?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 58 participants. The study started on 2018-05-30. Estimated completion is 2018-10-01.
What conditions does trial NCT03620708 study?
This clinical trial studies the following conditions: Tobacco Smoking.
What interventions are being tested in trial NCT03620708?
The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Nicotine Replacement Therapy Sampling (DRUG), Referral Only (BEHAVIORAL).
Who is sponsoring clinical trial NCT03620708?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03620708 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03620708's enrollment target sits among peer trials
58 25th of 38 higher than 14 of 38 other Tobacco Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
RECRUITING · Phase 4
-
Smoking Cessation Program in the Construction Sector
RECRUITING · Phase 4
-
Intervention to Increase Intention to Change Alcohol/Tobacco Use in Veterans With Chronic Disease
RECRUITING · Phase 3
-
Effects of Cannabidiol on Stress and Nicotine Withdrawal
RECRUITING · Phase 1
-
Cannabidiol for Reducing Cigarette Use
RECRUITING · Phase 2
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI